ResMed agrees to sell MatrixCare business to Frazier Healthcare Partners

ResMed Inc.

ResMed Inc.

RMD

0.00
  • ResMed agreed to sell its MatrixCare software business to private equity firm Frazier Healthcare Partners.
  • Deal refocuses the group’s strategy on sleep health, breathing health, and connected home-based care.
  • MatrixCare serves more than 15,000 providers across post-acute and long-term care settings.
  • Transaction includes MatrixCare-branded offerings such as Healthcare First and Citus; Brightree and MEDIFOX DAN are excluded.
  • Closing targeted for the first quarter of fiscal 2027, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-297658), on July 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.